Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Cyclopharm Limited ( (AU:CYC) ).
Cyclopharm Limited has announced its Annual General Meeting, scheduled for May 30, 2025, in Kingsgrove, NSW. The meeting will address several key resolutions, including financial statements, director re-election, and approval of performance rights and remuneration. This meeting is crucial for stakeholders as it will determine strategic decisions impacting the company’s governance and financial strategies.
More about Cyclopharm Limited
Cyclopharm Limited operates in the healthcare industry, focusing on the development and distribution of medical and healthcare products. The company is known for its specialized services and products aimed at improving patient outcomes and enhancing healthcare delivery.
YTD Price Performance: -27.85%
Average Trading Volume: 136,964
Technical Sentiment Signal: Buy
Current Market Cap: A$126.7M
For an in-depth examination of CYC stock, go to TipRanks’ Stock Analysis page.